Soleno Therapeutics to Participate in Upcoming June Conferences

Rhea-AI Summary

Soleno Therapeutics (NASDAQ: SLNO), a biopharmaceutical company focused on rare disease therapeutics, has announced its participation in two major healthcare conferences in June 2025:

- Jefferies Global Healthcare Conference: Corporate presentation scheduled for Wednesday, June 4, 2025, at 10:30 AM ET

- Goldman Sachs 46th Healthcare Conference: Corporate presentation scheduled for Tuesday, June 10, 2025, at 8:40 AM ET

Both presentations will be available for replay in the Investors section of Soleno's website.

News Market Reaction

-2.33%

1 alert

-2.33% News Effect

On the day this news was published, SLNO declined 2.33%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the following investor conferences in June:

Jefferies Global Healthcare Conference
Presentation Date: Wednesday, June 4, 2025 at 10:30 AM ET
Presentation Format: Corporate Presentation
Webcast: Here

Goldman Sachs 46^th Healthcare Conference
Presentation Date: Tuesday, June 10, 2025 at 8:40 AM ET
Presentation Format: Corporate Presentation
Webcast: Here

A replay of both events will be available in the Investors section on the Company’s website at www.soleno.life.

About Soleno Therapeutics, Inc.

Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The Company’s first commercial product, VYKAT™ XR (diazoxide choline) extended-release tablets, formerly known as DCCR, is a once-daily oral treatment for hyperphagia in adults and children four years of age and older with Prader-Willi syndrome. For more information, please visit www.soleno.life.

Corporate Contact:
Brian Ritchie
LifeSci Advisors, LLC
212-915-2578

FAQ

When is Soleno Therapeutics (SLNO) presenting at the Jefferies Global Healthcare Conference in 2025?

Soleno Therapeutics will present at the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025, at 10:30 AM ET.

What time is Soleno Therapeutics' presentation at the Goldman Sachs Healthcare Conference in June 2025?

Soleno Therapeutics will present at the Goldman Sachs Healthcare Conference on Tuesday, June 10, 2025, at 8:40 AM ET.

Where can investors access the replay of Soleno Therapeutics' June 2025 conference presentations?

Replays of both conference presentations will be available in the Investors section of Soleno Therapeutics' website at www.soleno.life.

What type of company is Soleno Therapeutics (SLNO)?

Soleno Therapeutics is a biopharmaceutical company that develops novel therapeutics for the treatment of rare diseases.